WHO ICTRP trial
Effect of granulocyte-macrophage colony-stimulating factor concurrent with…
ChiCTR2200055547 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200055547 |
|---|---|
| Public title | Effect of granulocyte-macrophage colony-stimulating factor concurrent with intensity-modulated radiotherapy on T-lymphocyte homeostasis in patients with metastatic solid tumors |
| Scientific title | Safety and immune efficacy of GM-CSF in combination with precision radiotherapy in the treatment of metastatic solid tumors |
| Primary sponsor | Affiliated Hospital of Medical College of Qingdao University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Advanced solid tumors |
| Interventions | Experimental group:GM-CSF + radiotherapy;control group:radiotherapy |
| Registration date | Jan 11, 2022 |
| Target size | Experimental group:24;control group:24 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: